WDB coco Co Ltd
TSE:7079
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
2 865
4 900
|
| Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
WDB coco Co Ltd
WDB coco Co Ltd
Cost of Revenue
WDB coco Co Ltd
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
WDB coco Co Ltd
TSE:7079
|
Cost of Revenue
-¥2.7B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
N/A
|
|
|
CMIC Holdings Co Ltd
TSE:2309
|
Cost of Revenue
-¥72.3B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-6%
|
|
|
C
|
Chiome Bioscience Inc
TSE:4583
|
Cost of Revenue
-¥269.9m
|
CAGR 3-Years
0%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-6%
|
|
|
Precision System Science Co Ltd
TSE:7707
|
Cost of Revenue
-¥3B
|
CAGR 3-Years
21%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-1%
|
|
|
Medinet Co Ltd
TSE:2370
|
Cost of Revenue
-¥624.2m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
1%
|
CAGR 10-Years
5%
|
|
|
CellSource Co Ltd
TSE:4880
|
Cost of Revenue
-¥1.3B
|
CAGR 3-Years
-30%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
N/A
|
|
WDB coco Co Ltd
Glance View
WDB coco Co., Ltd. engages in the safety information management business. The company is headquartered in Chuo-Ku, Tokyo-To and currently employs 403 full-time employees. The company went IPO on 2019-12-25. The firm is engaged in the provision of safety information management service as an agent and support for drug development, document support service, development support service and clinical development support service. The safety information management service provides support services such as input, evaluation drafting and report drafting. The document support service provides support services from QC (quality assurance) and translation of documents and materials necessary for marketing approval to PMDA (Pharmaceuticals and Medical Devices Agency) to the creation of approval application called CTD (Common Technical Document). The development support service provides services such as survey form management, filing of survey-related documents and call center operations. The clinical development support service provides support services for clinical trial related work.
See Also
What is WDB coco Co Ltd's Cost of Revenue?
Cost of Revenue
-2.7B
JPY
Based on the financial report for Mar 31, 2024, WDB coco Co Ltd's Cost of Revenue amounts to -2.7B JPY.
What is WDB coco Co Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-17%
Over the last year, the Cost of Revenue growth was -7%. The average annual Cost of Revenue growth rates for WDB coco Co Ltd have been -17% over the past three years , -17% over the past five years .
You don't have any saved screeners yet
